AI Image
FDA recalls thousands of blood pressure bottles after it failed quality tests
WCVB • • health
Key Points:
- The FDA has issued a nationwide recall of certain blood pressure medications produced by Macleods Pharma USA due to quality concerns.
- The recall, initiated on October 7, 2026, and classified as Class II on October 26, 2026, affects specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets.
- A Class II recall indicates the medication may cause temporary or medically reversible adverse health effects.
- The recall includes 3,528 bottles of 30-count (lot 12251163A) and 216 bottles of 90-count (lot 12251163B), all expiring on May 31, 2027.
- The affected medication failed quality tests because the pills did not dissolve properly, potentially impacting their effectiveness.
